Active

Portal Innovations

Investor type

VC

Founded

2020

AUM

$100 M

Location

Chicago, Illinois, United States

Investment Ticket

$10-50 m

Investment Stage

Series B Series A Seed Pre-seed

Region of investment

North America Australia and others
Investor profile last updated: 03 September, 2026

Profile

Portal Innovations is a venture capital firm based in Chicago, Illinois, founded in 2020. The firm specializes in supporting life sciences, medtech, and bioinformatics startups by providing seed capital, lab space, and management expertise. Portal Innovations operates with a team of 30 professionals and has a presence in multiple locations, including Chicago, Providence, and New Brunswick.

The firm focuses on investing in early-stage companies, particularly in the life sciences and healthcare sectors. It typically supports Series A and seed-stage startups, primarily in the United States, with some investments in Australia. Portal Innovations manages the Velocity Fund, which has an AUM of $100 million, launched in 2025.

Notable portfolio companies include Moonlight Therapeutics - clinical trials, Syntax Bio - drug discovery, CrossBridge Bio - acquired by Eli Lilly, Syntis Bio - drug discovery, and March Biosciences - drug discovery. These investments highlight Portal Innovations' commitment to advancing scientific breakthroughs in the biotech and healthcare industries.

Industry

Life Sciences HealthTech MedTech Pharmaceuticals Medical Devices Healthcare Services Biotechnology Technology

Portal Innovations Funds

Name Type
Questionare
Industry
Questionare
Stage
Questionare
Region
Size AUM Launch date
Velocity Fund
Venture Capital (VC)
Healthcare Services
MedTech
Technology
HealthTech
Pre-seed
Seed
North America
$5-10 m
$100 M
August 2025
Woodbine Labs, Powered by Portal
Venture Capital (VC)
Biotechnology
Life Sciences
Seed
Series A
Series B
North America
$1-5 m
March 2026

Contacts

Name
Title
Email
avatar
John Flavin, MBA Founder & CEO
Founder & CEO
j•••@•••
avatar
Yolaine Robitaille Director of Business Development
Director of Business Development
y•••@•••
Upgrade to see contacts
avatar
j5be2IzrqPm9cXok j5be2IzrqPm9cXok
j5be2IzrqPm9cXok
avatar
j5be2IzrqPm9cXok j5be2IzrqPm9cXok
j5be2IzrqPm9cXok
avatar
j5be2IzrqPm9cXok j5be2IzrqPm9cXok
j5be2IzrqPm9cXok
Investment-team contacts for Portal Innovations — including verified work emails and LinkedIn profiles — are available to Private Equity List subscribers.
Instant access on the web. Plans from $129/month — see pricing.
Contacts sourced from the firm's website and LinkedIn, re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.

FAQs about Portal Innovations

Portal Innovations is a venture capital firm. It backs companies at Series B, Series A, Seed and Pre-seed, writing tickets of $10-50 m.
Portal Innovations is located in Chicago, Illinois, United States.
Portal Innovations was founded in 2020.
Portal Innovations invests in companies and startups in Life Sciences, HealthTech, MedTech, Pharmaceuticals, Medical Devices, Healthcare Services, Biotechnology, Technology.
Portal Innovations invests in companies and startups in North America, Australia and others.
Portal Innovations invests in companies and startups at Series B, Series A, Seed, Pre-seed.
Portal Innovations usually invests $10-50 m on average.
Portal Innovations has around $100m assets under management.
Portal Innovations last fund was created/launched in 2026-03-10
Portal Innovations can be reached through its website portalinnovations.com, its LinkedIn page and its X account. Its general enquiries address is [email protected]. Cold-mailing a general inbox rarely reaches a partner, so Private Equity List also lists the investment-team contacts for Portal Innovations — names, roles, verified work emails and LinkedIn profiles — available on a Pro plan from $129/month (see pricing). Contacts are sourced from the firm's website and LinkedIn and re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.
Yes. Every field on this page — profile, funds, investment criteria, portfolio and investment-team contacts — is available programmatically through the Private Equity List REST API and MCP server, so AI assistants such as Claude and ChatGPT can query Portal Innovations directly instead of scraping this page. One subscription covers both the web app and machine access — see API & MCP.
Private Equity List re-verifies investor profiles on a rolling cycle, pulling from the firm's own website and LinkedIn rather than a one-off import. This profile was last updated on 03 September, 2026. Something out of date here? Report it — we re-run that firm within 48h and get back to you.